US based IT security company Forescout Technologies has upgraded and renamed its SilentDefense security product to beef up protection for IoT.
Forescout claims the new product, now named eyeInspect, “is the only solution that continuously identifies, segments, and enforces compliance of every connected thing.”
Forescout says eyeInspect integrates with its eyeSegment product — a cloud-based offering launched in November 2019 to help organisations accelerate network segmentation projects — to simplify and streamline enterprise segmentation, and with the Medigate medical device security and asset management system (Forescout announced its partnership with Medigate earlier this year “to help healthcare organisations accurately and comprehensively identify, monitor and secure every medical device on the clinical network.”)
It says new integrations let organisations reduce attack surface, maintain compliance and minimise breach impact across IT, IoT, healthcare and OT environments, and “continuous monitoring of segmentation hygiene provides an instant understanding of new risks due to the expanded interconnectivity between traditional IT, cyber-physical and clinical technology domains.”
The company is promising, later this year, a new user interface that will streamline network monitoring, threat alerting and risk mitigation workflows for security operations teams.
Acquisition by Advent International underway
In February 2020 private investment company Advent International announced plans to acquire NASDAQ listed Forescout Technologies for $US1.9 billion, $US33.00 per share. In May Forescout filed a complaint with a US court asserting that affiliates of Advent International had violated the terms of their merger agreement. Then in July Forescout announced the deal was back on at $US29.00 per share.